300 related articles for article (PubMed ID: 30674873)
1. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
Xiang L; Mou J; Shao B; Wei Y; Liang H; Takano N; Semenza GL; Xie G
Cell Death Dis; 2019 Jan; 10(2):40. PubMed ID: 30674873
[TBL] [Abstract][Full Text] [Related]
2. Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.
Huang F; Zhang Q; Ma H; Lv Q; Zhang T
Int J Clin Exp Pathol; 2014; 7(3):1093-100. PubMed ID: 24696726
[TBL] [Abstract][Full Text] [Related]
3. Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
Li J; Song P; Jiang T; Dai D; Wang H; Sun J; Zhu L; Xu W; Feng L; Shin VY; Morrison H; Wang X; Jin H
Mol Ther; 2018 Jul; 26(7):1828-1839. PubMed ID: 29730197
[TBL] [Abstract][Full Text] [Related]
4. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.
Lu WQ; Hu YY; Lin XP; Fan W
Oncotarget; 2017 Jul; 8(27):44171-44185. PubMed ID: 28498807
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
7. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J
Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856
[TBL] [Abstract][Full Text] [Related]
8. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
[TBL] [Abstract][Full Text] [Related]
9. GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway.
Liu HY; Zhang HS; Liu MY; Li HM; Wang XY; Wang M
Arch Biochem Biophys; 2021 Sep; 708():108964. PubMed ID: 34119480
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
Hu M; Liu L; Yao W
Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
Qie S; Chu C; Li W; Wang C; Sang N
J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
[TBL] [Abstract][Full Text] [Related]
13. Glutaminase (GLS1) gene expression in primary breast cancer.
Vidula N; Yau C; Rugo HS
Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
[TBL] [Abstract][Full Text] [Related]
14. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
Song Z; Wei B; Lu C; Li P; Chen L
Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
[TBL] [Abstract][Full Text] [Related]
15. Targeting GLS1 to cancer therapy through glutamine metabolism.
Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
[TBL] [Abstract][Full Text] [Related]
16. Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance.
Cao J; Zhang C; Jiang GQ; Jin SJ; Gao ZH; Wang Q; Yu DC; Ke AW; Fan YQ; Li DW; Wang AQ; Bai DS
Mol Med Rep; 2019 Aug; 20(2):1915-1924. PubMed ID: 31257527
[TBL] [Abstract][Full Text] [Related]
17. Increased Expression of Glutaminase in Osteoblasts Promotes Macrophage Recruitment in Periapical Lesions.
Hou KL; Lin SK; Kok SH; Wang HW; Lai EH; Hong CY; Yang H; Wang JS; Lin LD; Chang JZ
J Endod; 2017 Apr; 43(4):602-608. PubMed ID: 28190586
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State.
Daemen A; Liu B; Song K; Kwong M; Gao M; Hong R; Nannini M; Peterson D; Liederer BM; de la Cruz C; Sangaraju D; Jaochico A; Zhao X; Sandoval W; Hunsaker T; Firestein R; Latham S; Sampath D; Evangelista M; Hatzivassiliou G
Cell Metab; 2018 Sep; 28(3):383-399.e9. PubMed ID: 30043751
[TBL] [Abstract][Full Text] [Related]
19. Glutaminase 1 is essential for the differentiation, proliferation, and survival of human neural progenitor cells.
Wang Y; Huang Y; Zhao L; Li Y; Zheng J
Stem Cells Dev; 2014 Nov; 23(22):2782-90. PubMed ID: 24923593
[TBL] [Abstract][Full Text] [Related]
20. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A
Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
